Company Overview and News

Lee & Man, SmarTone, Great Eagle and China New Higher Education to the fore in strong week of share buying

2018-03-11 scmp
Sixteen firms record 69 purchases worth HK$121 million (US$15.4m) versus eight firms with 29 disposals worth HK$58 million

Communication Services Top Gain Stocks Are Consolidated, VEON, China Mobile And Vodafone Per Broker December Targets

2017-12-28 seekingalpha
Gains in telecom services moved offshore this month like outcasts as overseas firms dominated analyst 1yr. targets.

Communication Services Top Gain Stocks Are Consolidated, VEON, China Mobile & Vodafone Per Broker December Targets

2017-12-28 seekingalpha
Gains in telecom services moved offshore this month like outcasts as overseas firms dominated analyst 1yr. targets.

Hutchison sells Hong Kong fixed-line business to I Squared for $1.9 billion

2017-07-30 livemint
Hong Kong: Hutchison Telecommunications Hong Kong Holdings Ltd said on Sunday it agreed to sell its fixed-line telecoms business to I Squared Capital for about $1.9 billion, raising funds to invest into mobile phone services and for working capital.

2Q16 Asia Pacific Mobile Operator Forecast, 2002 - 2018

2017-02-07 prnewswire
LONDON, Feb. 6, 2017 /PRNewswire/ -- IEMR's Asia Pacific Mobile Operator Forecast is the most comprehensive forecast of its kind in the world. This report provides operational and financial metrics for wireless markets across the region and is one of the best forecasts in the industry. We provide two-year forecasts at the operator level going out to 2018. We also provide quarterly historical and forecast data starting in 2002 and ending in 2Q.

Hong Kong should use regional benchmarks to price mobile spectrum

2016-11-28 scmp
Government should also free up more spectrum for innovation purposes and allow spectrum trading, HKT says

Buyback activity on Hong Kong exchange falls for first time in four weeks

2016-11-27 scmp
The buying slowed after rising for three straight weeks while the selling among directors rose for the second straight week based on filings on the Hong Kong exchange in the fourth week of November. Buyers outweighed sellers with 33 companies that recorded 163 purchases worth HK$323 million versus 15 firms with 56 disposals worth HK$45 million. The buy figures were slightly down from the previous week’s 34 companies, 187 purchases and HK$355 million.

Sale of Wharf's HK Telecom Unit Could Reportedly Reach Up to $1.2 Billion

2016-09-07 fortune
KKR & Co LP kkr and HKBN have placed final bids for the Hong Kong telecom arm of Wharf Holdings, warfy in a deal likely to fetch $1 billion to $1.2 billion, people familiar with the matter told Reuters.

Hong Kong’s SmarTone expects boost in revenue in bringing more bandwidth to city’s mobile users

2016-02-02 scmp
SmarTone Telecommunications Holdings, which runs the No 3 mobile network operator in Hong Kong, expects a steady rise in revenue as it takes the lead in bringing more bandwidth for the city’s data-hungry 4G mobile users.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...